Wireless implant monitors heart failure patients at home

NCT ID NCT02729922

Completed Knowledge-focused Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tracked 30 adults with advanced heart failure who received a CardioMEMS implant, a wireless sensor placed in the lung artery to monitor pressure. Patients sent data from home, and doctors used it to guide care. The goal was to see if this approach reduces hospital stays and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CardioMEMS implantable pulmonary artery sensor
What this could lead to: If successful, this registry could show that CardioMEMS helps reduce heart failure hospitalizations and improve quality of life.
What could go wrong: This is a small, completed registry with only 30 participants, so results may not apply to all heart failure patients. It is observational, not a controlled trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE，CONGESTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE，CONGESTIVE

Contacts and locations

Locations

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.